NCT04600466 2026-04-14
Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer
The University of Texas Health Science Center at San Antonio
Terminated
Clinical Trials
1,093 trialsNCT05567835 2026-04-09
TOGAR
Baylor College of Medicine
Phase 2 Terminated
NCT06034197 2026-04-08
Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy
Stanford University
Phase EARLY_PHASE1 Terminated
NCT07350590 2026-04-02
Comparison Between Robotic and Laparoscopic Right Hemicolectomy
Sir Run Run Shaw Hospital
Terminated
NCT03727633 2026-03-31
LIDA-BII
University Hospital, Montpellier
Phase 2 Terminated
NCT03085004 2026-03-30
CHARM
Milton S. Hershey Medical Center
Phase 3 Terminated
NCT03960021 2026-03-27
ARFIM
Institut Bergonié
Phase NA Terminated
NCT04523389 2026-03-24
ExoColon
Centre Hospitalier Universitaire Dijon
Terminated
NCT05131776 2026-03-23
EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.
Chinese University of Hong Kong
Phase 2/3 Terminated
NCT03301454 2026-03-18
E-DIS2
Centre Oscar Lambret
Phase 2 Terminated
NCT06181201 2026-03-18
Neo-Flo-Rect
Centre Oscar Lambret
Terminated
NCT02439008 2026-03-13
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
Centre Oscar Lambret
Phase NA Terminated
NCT03652298 2026-03-13
NeuroPrevPTSD
Centre Oscar Lambret
Phase 2 Terminated
NCT04777851 2026-03-09
REPLACE
Translational Research in Oncology
Phase 3 Terminated
NCT00748449 2026-03-06
COLO-TDM
Assistance Publique - Hôpitaux de Paris
Phase NA Terminated
NCT04327700 2026-03-05
Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib
Wake Forest University Health Sciences
Phase 2 Terminated
NCT04785287 2026-03-03
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT04975516 2026-03-03
Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer
Mayo Clinic
Phase 2 Terminated
NCT06851104 2026-02-18
A Prospective Study of Cadonilimab in Hepatocellular Carcinoma After Radical Surgery With High Risk of Recurrence
Guangxi Medical University
Phase 2 Terminated
NCT02738606 2026-02-17
Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT04387071 2026-02-17
CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma
University of Southern California
Phase 1/2 Terminated
NCT05442749 2026-02-17
PARPi-PANC
Centre Leon Berard
Phase 2 Terminated
NCT02724202 2026-02-06
Curcumin in Combination With 5FU for Colon Cancer
Baylor Research Institute
Phase EARLY_PHASE1 Terminated
NCT06197178 2026-02-06
A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)
Peking University
Phase 1 Terminated
NCT04990895 2026-02-05
A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys
AHS Cancer Control Alberta
Phase NA Terminated
NCT05489250 2026-02-05
PLATON
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Terminated
NCT03323944 2026-01-30
CAR T Cell Immunotherapy for Pancreatic Cancer
University of Pennsylvania
Phase 1 Terminated
NCT06290856 2026-01-29
Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy
Oslo University Hospital
Terminated
NCT06739252 2026-01-28
Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA
Peking University
Phase 2 Terminated
NCT05665322 2026-01-23
MARGIN
Centre Hospitalier Universitaire de Nīmes
Phase NA Terminated
NCT06006923 2026-01-20
Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer
University of Pittsburgh
Phase 2 Terminated
NCT05987176 2026-01-14
NELMAS
Imperial College London
Phase 2 Terminated
NCT02917759 2026-01-09
Liver and Biliary Tumor Tissue Registry
Mayo Clinic
Terminated
NCT06332079 2026-01-05
HAITI
Gruppo Oncologico del Nord-Ovest
Phase 2 Terminated
NCT03275974 2026-01-02
Glutamine PET Imaging Colorectal Cancer
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT03844750 2025-12-31
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases
University of California, San Francisco
Phase 2 Terminated
NCT04203160 2025-12-31
Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)
University of Michigan Rogel Cancer Center
Phase 1/2 Terminated
NCT04805788 2025-12-31
Stereotactic Body Proton Radiotherapy for the Treatment of Liver Cancer
Mayo Clinic
Phase 2 Terminated
NCT03042169 2025-12-23
SURGIGAST
University Hospital, Lille
Phase 3 Terminated
NCT06420349 2025-12-22
NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma
Mayo Clinic
Phase 1 Terminated
NCT05044676 2025-12-18
IMMUNOCELL
Assistance Publique - Hôpitaux de Paris
Terminated
NCT05171166 2025-12-18
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
Peking University
Phase 2/3 Terminated
NCT03676478 2025-12-10
EFECTS
University Hospital, Gasthuisberg
Phase NA Terminated
NCT05289830 2025-12-10
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT06199466 2025-12-08
A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT05114213 2025-12-05
MASPAC
Ludwig-Maximilians - University of Munich
Phase 2 Terminated
NCT05427396 2025-12-03
A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Terminated
NCT04779151 2025-12-01
NIRADO
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Terminated
NCT02885142 2025-11-18
MUCEM
Assistance Publique Hopitaux De Marseille
Phase NA Terminated
NCT05417386 2025-11-18
FOLFIRINOX + NIS793 in Pancreatic Cancer
Massachusetts General Hospital
Phase 1 Terminated